Spots Global Cancer Trial Database for A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer
Official Title: A Phase Ib/II Safety Trial of Nivolumab in Combination With Ipilimumab Administered in Participants With Chemotherapy-naive Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) (CheckMate 955: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 955)
Study ID: NCT03048136
Conditions
Study Description
Brief Summary: A Study to Evaluate Safety in Participants with Chemotherapy-naïve Stage IV or Recurrent Non-small Cell Lung Cancer Treated With Nivolumab in Combination with Ipilimumab
Detailed Description: A Study to Evaluate Safety in Participants with Chemotherapy-naïve Stage IV or Recurrent Non-small Cell Lung Cancer Treated With Nivolumab in Combination with Ipilimumab
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Local Institution, San Francisco, California, United States
Local Institution, Lincoln, Nebraska, United States
Local Institution, Hackensack, New Jersey, United States
Local Institution, Columbus, Ohio, United States
Local Institution, Lancaster, Pennsylvania, United States
Local Institution, Langhorne, Pennsylvania, United States
Local Institution, Sayre, Pennsylvania, United States
Local Institution, Charleston, South Carolina, United States
Local Institution, Saint George, Utah, United States
Local Institution, Viedma, RIO Negro, Argentina
Local Institution, Montreal, Quebec, Canada
Local Institution, Dresden, , Germany
Local Institution, Gauting, , Germany
Local Institution, Gerlingen, , Germany
Local Institution, Grosshansdorf, , Germany
Local Institution, Lima, , Peru
Local Institution, Lima, , Peru
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
